Astellas Pharma reported -12246000000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Astellas Pharma 4503:JP -12246000000 84.22B
Chugai Pharma 4519:JP 187.01B 47.94B
Daiichi Sankyo 4568:JP -50747000000 89.78B
Eisai 4523:JP -20803000000 34.45B
Kyowa Hakko Kirin 4151:JP 16.1B 714M
M3 2413:JP 12.61B 9.95B
Otsuka Holdings 4578:JP 42.23B 44.3B
Shionogi 4507:JP 49.89B 32.13B
Sumitomo Dainippon 4506:JP 2.01B 8.65B
Takeda 4502:JP -1619000000 144.87B
Terumo 4543:JP 21.51B 7.09B